SCHEMBL10568135

SCHEMBL10568135

COc1ccc(-c2cc(=S)n(C)c(=O)n2C)c(OC)c1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 2/20 0.40
▸ NQO2 P16083 2/20 0.40
▸ HDAC4 P56524 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ ACHE P22303 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ ERN1 O75460 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10566461 0.85 CYP19A1 (0.49) CYP19A1NQO2HDAC4HDAC2HDAC8
SCHEMBL10562633 0.78 L3MBTL1 (0.40) CYP19A1NQO2ALDH1A1KDM4EHPGD
SCHEMBL10567603 0.77 KDM4E (0.42) CYP19A1ALDH1A1KDM4EHPGDNPC1
SCHEMBL10571122 0.76 CYP3A4 (0.54) CYP19A1NQO2HDAC4HDAC2HDAC8
SCHEMBL10571125 0.76 CYP3A4 (0.54) CYP19A1NQO2HDAC4HDAC2HDAC8
SCHEMBL10568492 0.74 CRHR1 (0.40) KDM4ESMN1; SMN2HTT
SCHEMBL10364534 0.71 S100B (0.36) CYP19A1NQO2ALDH1A1KDM4EHPGD
SCHEMBL10567037 0.70 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDSMN1; SMN2MAPT
SCHEMBL10731467 0.69 PDGFRB (0.44) ALDH1A1SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL642228 0.68 HDAC4 (0.58) HDAC4HDAC2HDAC8ACHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4824851-A Pyrimidones as cardiotonic, anti hypertensive, cerebrovascular vasodilator and anti-platelet agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-04-25 — — US disclosed
EP-0123402-B1 PYRIMIDINE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-09-07 — — EP disclosed
US-4746664-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-05-24 — — US disclosed
US-4612376-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-09-16 — — US disclosed
EP-0123402-A2 Pyrimidine derivatives, preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 — — EP disclosed
Send feedback